View |
|
DRP-15216
|
Mycophenolic Acid
|
Mofecon-S 360
|
360 mg
|
Delayed-Release Tablet
|
Immunosuppressant
|
Concord Biotech Limited
|
India
|
Initial
|
29 May 2024
|
29 May 2029
|
View |
|
DRP-15248
|
Benzylpenicillin sodium.
|
Saphbenzillin-5M
|
5,000,000 IU (equivalent to 3 g)
|
Powder for Injection
(I.M./I.V.)
|
Penicillin Beta-lactam Antibacterial
|
Kilitch Drugs (India) Ltd.
|
India
|
Initial
|
31 May 2024
|
31 May 2029
|
View |
|
DRP-15250
|
Atracurium besilate
|
Curan
|
10 mg/mL (25 mg/2.5 mL)
|
Solution for Injection (I.V.)
|
Muscle Relaxant (Other Quaternary Ammonium
Compound)
|
Divine Laboratories Pvt. Ltd.
|
India
|
Initial
|
31 May 2024
|
31 May 2029
|
View |
|
HRP-649
|
Povidone Iodine
|
Zelec
|
0.075
|
Topical Solution
|
Antiseptic
|
Kohl Industries Corporation.
|
Philippines
|
Initial
|
31 May 2024
|
31 May 2026
|
View |
|
DRP-15261
|
Solifenacin (as succinate)
|
Dalisoon
|
5 mg
|
Film-Coated Tablet
|
Drug for Urinary Frequency and Incontinence
|
Standard Chem. & Pharm. Co., Ltd.
|
Taiwan
|
Initial
|
31 May 2024
|
31 May 2029
|
View |
|
DRP-15251
|
Sitagliptin (as phosphate monohydrate) + Metformin hydrochloride.
|
Novasit-M 50/1000
|
50 mg/1 g
|
Film-Coated Tablet
|
Blood Glucose Lowering Drug Combination
|
Novagen Healthcare Private Limited
|
India
|
Initial
|
31 May 2024
|
31 May 2026
|
View |
|
DRP-15252
|
Sitagliptin (as phosphate monohydrate) + Metformin hydrochloride
|
None
|
50 mg/1 g
|
Film-Coated Tablet
|
Blood Glucose Lowering Drug Combination.
|
Novagen Healthcare Private Limited
|
India
|
Initial
|
31 May 2024
|
31 May 2026
|
View |
|
DR-XY49101
`
|
Silver Sulfadiazine
|
Vexsilva
|
10 mg/g (1% w/w)
|
Cream
|
Chemotherapeutic for Topical Use (Sulfonamide)
|
Yash Pharmaceuticals
|
India
|
Initial
|
31 May 2024
|
31 May 2029
|
View |
|
DRP-15249
|
Silver Sulfadiazine
|
Amidozil
|
10 mg/g (1% w/w)
|
Topical Cream
|
Chemotherapeutic for Topical Use (Sulfonamide)
|
S Kant Healthcare Limited
|
India
|
Initial
|
31 May 2024
|
31 May 2029
|
View |
|
DR-XY49090
|
Capecitabine
|
Emcap 500
|
500 mg
|
Film-Coated Tablet
|
Antineoplastic
|
MSN Laboratories Private Limited (Formulations Division)
|
India
|
Initial (Reapplication)
|
31 May 2024
|
31 May 2029
|
View |
|
DRHR-2362
|
Isopropyl Alcohol
|
Alco 70
|
70 mL/100 mL (70% v/v)
|
Solution
|
Antiseptic/Disinfectant
|
Greenstone Pharmaceutical Inc.
|
Philippines
|
Initial [HR]
|
31 May 2024
|
31 May 2029
|
View |
|
DRP-15245
|
Paclitaxel
|
Welnano
|
100 mg
|
Lyophilized Powder for Suspension for IV
Infusion (Protein-bound particles)
|
Antineoplastic (Taxane)
|
Getwell Pharmaceuticals.
|
India
|
Initial
|
31 May 2024
|
31 May 2029
|
View |
|
DRP-15244
|
Paclitaxel
|
Taxinano
|
100 mg
|
Lyophilized Powder for Suspension for IV Infusion (Protein-bound particles)
|
Antineoplastic (Taxane)
|
Getwell Pharmaceuticals
|
India
|
Initial (Variation)
|
31 May 2024
|
31 May 2029
|
View |
|
DRP-15243
|
Paclitaxel
|
Paclinano
|
100 mg
|
Lyophilized Powder for Suspension for IV Infusion (Protein-bound particles)
|
Antineoplastic (Taxane)
|
Getwell Pharmaceuticals
|
India
|
Initial
|
31 May 2024
|
31 May 2029
|
View |
|
DRP-15246
|
Vildagliptin + Metformin HCI
|
None
|
50 mg/1 g
|
Tablet
|
Combination of oral blood glucose lowering drugs
|
Novagen Healthcare Private Limited.
|
India
|
Initial
|
31 May 2024
|
31 May 2026
|
View |
|
DRP-15247
|
Vildagliptin + Metformin HCI
|
None
|
50 mg/850 mg
|
Tablet
|
Combination of oral blood glucose lowering drugs
|
Novagen Healthcare Private Limited.
|
India
|
Initial
|
31 May 2024
|
31 May 2026
|
View |
|
DRP-10478-01
|
Metformin Hydrochloride
|
Metfor XR
|
500 mg
|
Extended Release Tablet
|
Oral hypoglycemic Agent (Biguanide)
|
Globela Pharma Private Limited
|
India
|
CLIDP Conversion
|
10 June 2024
|
30 September 2026
|
View |
|
DRP-10620-03
|
Azithromycin (as dihydrate)
|
Zithoret
|
500 mg
|
Film-Coated Tablet
|
Antibacterial (Macrolide)
|
Zim Laboratories Limited
|
India
|
CLIDP Conversion
|
15 June 2024
|
10 November 2026
|
View |
|
DRP-10671-05
|
Vitamin B-Complex + Iron + Lysine + Buclizine HCl
|
Danikid Plus
|
10 mg / 5 mg / 10 mcg / 10 mg / 125 mg / 5 mg per 5 mL
|
Syrup
|
Vitamin/Mineral/Amino Acid/Appetite Stimulant
|
Lloyd Laboratories, Inc
|
Philippines
|
CLIDP Conversion
|
10 June 2024
|
05 October 2026
|
View |
|
DRP-10721-06
|
Dapagliflozin
|
Zydhar 10
|
10 mg
|
Film-Coated Tablet
|
Blood glucose lowering drug [Sodium-glucose co-transporter 2 (SGLT2) Inhibitor]
|
Lloyd Laboratories, Inc.
|
Philippines
|
CLIDP Conversion
|
10 June 2024
|
11 November 2026
|